Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges

Author:

Adachi Takeya123ORCID,El-Hattab Ayman W.456ORCID,Jain Ritu789ORCID,Nogales Crespo Katya A.10ORCID,Quirland Lazo Camila I.111213,Scarpa Maurizio141516ORCID,Summar Marshall1718192021,Wattanasirichaigoon Duangrurdee2223242526272829ORCID

Affiliation:

1. Department of Dermatology, Keio University School of Medicine, Tokyo 160-8582, Japan

2. Department of Medical Regulatory Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

3. United Japanese-Researchers Around-the-World (UJA), Isehara 259-1143, Japan

4. Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates

5. MENA (Middle East and North Africa) Organization for Rare Diseases, Dubai 500767, United Arab Emirates

6. Department of Pediatrics, University Hospital Sharjah, Sharjah 72772, United Arab Emirates

7. Dystrophic Epidermolysis Bullosa Research Association (DEBRA), Singapore 059811, Singapore

8. Asia Pacific Alliance of Rare Disease Organizations (APARDO), Singapore 188976, Singapore

9. Language and Communication Centre, School of Humanities and Social Sciences, Nanyang Technological University, Singapore 639798, Singapore

10. Policy Wisdom LLC, Quebradillas 00678-2705, Puerto Rico

11. Health Technology Assessment Unit, Cancer Research Department, Arturo López Perez Foundation, Santiago 7500921, Chile

12. School of Medicine, Universitat Autònoma de Barcelona, 080193 Barcelona, Spain

13. Faculty of Pharmaceutical and Chemical Sciences, University of Chile, Santiago 8380000, Chile

14. European Reference Network for Hereditary Metabolic Diseases (MetabERN), 33100 Udine, Italy

15. Regional Coordinating Center for Rare Diseases Friuli Venezia Giulia, Udine University Hospital, 33100 Udine, Italy

16. Brains for Brain Foundation, 35128 Padova, Italy

17. The Translational Science Training Program, National Institutes of Health (NIH), Maryland, MD 20814, USA

18. Children’s National Medical Centre, Washington, DC 20010, USA

19. National Organization for Rare Disorders (NORD), Quincy, MA 02169, USA

20. Children’s National Rare Disease Institute, Washington, DC 20012, USA

21. Department of Pediatrics, George Washington University, Washington, DC 20052, USA

22. Thai Rare Disease Foundation (ThaiRDF), Bangkok 10230, Thailand

23. Prader-Willi Syndrome Association (PWSA) of Thailand, Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand

24. Rare Disease Working Committee, Thai National Health Security Office (NHSO), Bangkok 10210, Thailand

25. Sub-Working Committee for Rare Disease Medicine, Thailand National List of Essential Medicines (NLEM), National Drug Policy Division, Food and Drug Administration, Nonthaburi 11000, Thailand

26. Medical Genetics Network, Genetics Society of Thailand, Bangkok 10330, Thailand

27. Thailand Medical Genetics and Genomics Association (TMGGA), Bangkok 10510, Thailand

28. Asia Pacific Society of Human Genetics (APSHG), Singapore 229899, Singapore

29. Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand

Abstract

This document provides a comprehensive summary of evidence on the current situation of rare diseases (RDs) globally and regionally, including conditions, practices, policies, and regulations, as well as the challenges and barriers faced by RD patients, their families, and caregivers. The document builds on a review of academic literature and policies and a process of validation and feedback by a group of seven experts from across the globe. Panelists were selected based on their academic merit, expertise, and knowledge regarding the RD environment. The document is divided into five main sections: (1) methodology and objective; (2) background and context; (3) overview of the current situation and key challenges related to RDs covering six dimensions: burden of disease, patient journey, social impact, disease management, RD-related policies, and research and development; (4) recommendations; and (5) conclusions. The recommendations are derived from the discussion undertaken by the experts on the findings of this review and provide a set of actionable solutions to the challenges and barriers to improving access to RD diagnosis and treatment around the world. The recommendations can support critical decision-making, guiding efforts by a broad range of RDs stakeholders, including governments, international organizations, manufacturers, researchers, and patient advocacy groups.

Funder

Takeda Pharmaceutical Company Limited

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference183 articles.

1. Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group;Richter;Value Health,2015

2. National Health Security Office (2022, August 04). 24 Rare Diseases Added to UCS But Challenges Remain [Internet], Available online: https://eng.nhso.go.th/view/1/DescriptionNews/24-Rare-Diseases-Added-to-UCS-But-Challenges-Remain/292/EN-US.

3. Rare Diseases International (2022, August 04). Agreement with the WHO [Internet]. Available online: https://www.rarediseasesinternational.org/working-with-the-who/.

4. Rare Diseases International (2022, August 04). Operational Description of Rare Diseases [Internet]. Available online: https://www.rarediseasesinternational.org/wp-content/uploads/2022/08/INFOGRAPHIC-OPERATIONAL-DESCRIPTION-OF-RARE-DISEASES.pdf.

5. How many rare diseases are there?;Haendel;Nat. Rev. Drug Discov.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3